9989 — Shenzhen Hepalink Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapValue Trap

Market Cap
HK$4.14bn
Enterprise Value
HK$7.85bn
Revenue
CNY5.45bn

Annual balance sheet for Shenzhen Hepalink Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,329	3,541	3,873	3,334	2,211
Net Total Accounts Receivable
Net Total Receivables	1,752	2,026	1,938	1,927	1,583
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,996	9,129	10,770	12,390	10,604
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,576	2,571	2,537	2,477	2,634
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	15,242	19,026	19,108	20,816	19,203
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,967	3,613	4,791	5,576	4,986
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	7,895	7,457	7,697	8,503	7,290
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,347	11,569	11,411	12,313	11,913
Total Liabilities & Shareholders' Equity	15,242	19,026	19,108	20,816	19,203
Total Common Shares Outstanding